Concepedia

Krikor Bornazyan

KB

4

Publications

1.8K

Citations

4

H-Index

2017

Active since

Affiliations

University of California, Los Angeles(Current)

Krikor Bornazyan is an author at University of California, Los Angeles specializing in radiation oncology, medicine, and oncology.

Top concepts

Publications per year

2017–2018

4

Publications

4

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan et al. · The Lancet Oncology · 2017 · 1.1K citations · Full text

, , +9

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

Aaron Lisberg, Amy L. Cummings, Jonathan W. Goldman et al. · Journal of Thoracic Oncology · 2018 · 577 citations · Full text

, , +7

Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman et al. · Cancer Immunology Research · 2018 · 102 citations

Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation

Charlene M. Fares, Timothy J. Williamson, Matthew K. Theisen et al. · JCO Clinical Cancer Informatics · 2018 · 25 citations

Rows per page

1–4 of 4